Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline SBLK Q1 2026 Earnings EPS Surges Past Estimates Stock Declines CSV Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Signals GECCI Q1 2026 Earnings EPS Surges Past Estimates as Investment Income Strengthens Brookfield Renewable Corporation BEPC Q1 2026 Earnings WiderthanExpected Loss Amid Operational Headwinds FRMEP Q1 2026 Earnings Preferred Shares Exceed Expectations with 895 EPS Surprise PSMT Q1 2026 Earnings EPS Beats Estimates by 28 as Stock Barely Moves NTGR Q1 2026 Earnings Significant EPS Beat Signals Turnaround Progress Hub Group Q3 2025 Earnings Slight EPS Miss Amid Mixed Freight Conditions REGCO Q1 2026 Earnings Preferred Stock EPS Beats Estimates Stock Edges Lower GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain SKWD Q1 2026 Earnings EPS Surges Past Estimates Despite Limited Revenue Disclosure Natuzzi SpA NTZ Q4 2011 Earnings EPS Falls Short as Restructuring Weighs on Results